Showing 2901-2910 of 3315 results for "".
- Kala Pharmaceuticals Receives FDA Approval of Dry Eye Disease Treatment Eysuvishttps://modernod.com/news/kala-pharmaceuticals-announces-fda-approval-of-dry-eye-disease-treatment-eysuvis/2478460/The FDA on Tuesday approved Kala Pharmaceuticals’ Eysuvis (loteprednol etabonate ophthalmic suspension 0.25%), making it the first ocular corticosteroid for the treatment of dry eye disease and the first drug approved specifically for the short-term (up to 2 weeks) treatment of the signs an
- Visus Therapeutics Expands Clinical Advisory Board With Appointment of Renowned Ophthalmologistshttps://modernod.com/news/visus-therapeutics-expands-clinical-advisory-board-with-appointment-of-renowned-ophthalmologists/2478453/Visus Therapeutics announced the appointments of prominent ophthalmologists Marguerite McDonald, MD, Neda Shamie, MD, William Trattler, MD, and Lawrence Woodard, MD, to its clinical advisory board. Drs. McDonald, Shamie, Trattler and Woodard will lend their decades of experience in clinical pract
- Gilead’s Veklury Becomes First Treatment to Receive FDA Approval for COVID-19https://modernod.com/news/gileads-veklury-becomes-first-treatment-to-receive-fda-approval-for-covid-19/2478451/Gilead Sciences said Thursday that Veklury (remdesivir) has been approved by the FDA to treat hospitalized COVID-19 patients aged 12 years and older and weighing at least 40 kg, making it the first drug to gain full clearance in the US for the disease. The antiviral, which works by hindering the
- Azura Ophthalmics Raises $20 Million for Registration Studies for Treatment of Meibomian Gland Dysfunctionhttps://modernod.com/news/azura-ophthalmics-raises-20-million-for-registration-studies-for-treatment-of-meibomian-gland-dysfunction/2478445/Azura Ophthalmics announced a $20 million financing to advance Azura’s lead product candidate AZR-MD-001 through a registration study for the treatment of meibomian gland dysfunction (MGD). Azura’s novel medicines in development are designed to address abnormal hyperkeratinization – the bu
- Study Reveals Significant Restoration of Retinal and Visual Function Following Gene Therapyhttps://modernod.com/news/study-reveals-significant-restoration-of-retinal-and-visual-function-following-gene-therapy/2478443/A breakthrough study, led by researchers from the University of California, Irvine, showed significant restoration of retinal and visual function following gene therapy in mice models suffering from inherited retinal disease. Published in Nature Biomedical Engineering, the paper,
- Allergan Announces Updates to Eye Care Optometric Professional Relations Teamhttps://modernod.com/news/allergan-announces-updates-to-eye-care-optometric-professional-relations-team/2478432/Allergan Eye Care announced the retirement of Dave Gibson, Associate VP of Consumer Eye Care and Customer Development, after 20 years of service. Since 2009, Mr. Gibson has led Allergan’s Optometric Professional Relations team and helped launch a variety of programs to support the optometry com
- Blue Light Glasses Improve Sleep and Work Productivity, IU Research Showshttps://modernod.com/news/blue-light-glasses-improve-sleep-and-work-productivity-iu-research-shows/2478421/During the pandemic, the amount of screen time for many people working and learning from home as well as binge-watching TV has sharply increased. New research finds that wearing blue light glasses
- BVI Acquires Benz Research & Development, Strengthening IOL Design, Production and Sales Capabilitieshttps://modernod.com/news/bvi-acquires-benz-research-development-strengthening-iol-design-production-and-sales-capabilities/2478419/BVI announced its recent completion of the acquisition of Benz Research & Development and its customized contact lens subsidiary, SpecialEyes, both based in Sarasota, Florida. Terms of the deal were not disclosed. The Benz portfolio of performanc
- Hoya Surgical Optics Announces Global Launch of CLEARlog Apphttps://modernod.com/news/hoya-surgical-optics-announces-global-launch-of-clearlog-app/2478409/During the virtual ESCRS, the CLEARlog app was launched with the support of Hoya Surgical Optics. CLEARlog, which stands for “Cataract & Lens Exchange Analysis & Register” log, is an app that allows Cataract and Refractive Lens Exchange (RLE) surgeons to quickly and eff
- Santen Joins Forces With Ophthalmologists in the Fight Against Antibiotic Resistancehttps://modernod.com/news/santen-joins-forces-with-ophthalmologists-in-the-fight-against-antibiotic-resistance/2478406/Santen announced the launch of the Re-SOLVE Antibiotic Resistance initiative, which aims to lead the way in the fight against antibiotic resistance in ophthalmology. The initiative will promote and encourage good antibiotic stewardship—a set of actions for the sustainable and effective use of ant